Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Institute of Pharmaceutical Industry
Wuhan, Hubei, China
- Ownership
- Private
- Employees
- ~400
- Development stage
- Other
01
Overview
Hubei Institute of Pharmaceutical Industry operates as a primary R&D subsidiary for Humanwell Healthcare, focusing on the development of chemical drugs, including high-end generics and innovative small molecules in the fields of analgesia, cardiovascular health, and anti-infectives.
- Therapeutic areas
- OtherCardiovascularNeurologyInfectious DiseasesPulmonology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Humanwell Healthcare
Beyond the preview
Go deeper on Hubei Institute of Pharmaceutical Industry.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hubei Institute of Pharmaceutical Industry.